This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Biorion Technologies B.v., Rijksuniversiteit Groningen, Stichting Voor De Technische Wetenschappen. Active years: 2005-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
2 out of 58 
2 out of 82 Years Active: 2005-2019
Title: Eleonora Beljaars: Advancing Medicine through Interferon Analog Patents
Introduction:
Eleonora Beljaars, a talented inventor and researcher based in Groningen, Netherlands, has made significant contributions to the field of medicine through her innovative patents. With a passion for developing analogs of interferons (IFNs) that exhibit fewer side effects and improved therapeutic uses, Beljaars has established herself as a prominent figure in the pharmaceutical industry.
Latest Patents:
Among her remarkable achievements, Beljaars has obtained four patents, with her latest contributions focused on interferon analogs. These patents explore the development of biologically active IFN analogs that offer reduced undesirable side effects and enhanced therapeutic potential. Beljaars' inventions involve disrupting the moiety responsible for natural receptor binding in the analogs and integrating a signaling moiety capable of mediating intracellular IFN activity. Moreover, these analogs are equipped with targeting domains that bind to cell surface receptors, distinct from the IFN receptor.
Career Highlights:
Throughout her career, Beljaars has worked with prestigious organizations dedicated to technological sciences and research. Notably, she has contributed to the successes of "Stichting Voor De Technische Wetenschappen" and the esteemed "Rijksuniversiteit Groningen." Her groundbreaking work and commitment to advancing medical innovation have earned her recognition within the scientific community.
Collaborations:
Beljaars has had the privilege of collaborating with esteemed colleagues who possess expertise in various fields. Notable collaborators include Klaas Poelstra and Detlef Bruno Igor Schuppan, both of whom have enhanced Beljaars' research endeavors. Through these collaborations, she has been able to leverage diverse knowledge and perspectives, further driving her explorations in interferon analog development.
Conclusion:
Eleonora Beljaars stands as a pioneering inventor within the medical and pharmaceutical industry. Her ground-breaking patents in interferon analogs have the potential to revolutionize therapeutic approaches, offering improved effectiveness and reduced side effects. With an impressive career trajectory and a commitment to scientific advancement, Beljaars continues to contribute to the progression of medicine and innovation in the field of patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile